rs121918324
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001350129.2(PPOX):c.-253C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001350129.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461892Hom.: 0 Cov.: 38 AF XY: 0.00000825 AC XY: 6AN XY: 727246
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Variegate porphyria Pathogenic:2Other:1
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with porphyria variegate (MIM#176200). (I) 0107 - This gene is associated with autosomal dominant disease. Double heterozygotes have been reported (GeneReviews). (I) 0112 - The condition associated with this gene has incomplete penetrance (GeneReviews, PMID: 21910705). (I) 0115 - Variants in this gene are known to have variable expressivity. Symptoms are more common in women, and acute manifestations are highly variable and can become chronic (GeneReviews). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated amino-oxidase domain (DECIPHER). (I) 0801 - This variant has very strong previous evidence of pathogenicity in unrelated individuals. It is known as a founder allele introduced by the Dutch settlers to South Africa, where it accounts for 95% of variegate porphyria cases (GeneReviews, PMID: 21910705). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
- -
- -
not provided Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 59 of the PPOX protein (p.Arg59Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with variegate porphyria (PMID: 8673113, 8817334). It is commonly reported in individuals of South African ancestry (PMID: 8673113, 8817334). ClinVar contains an entry for this variant (Variation ID: 8696). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PPOX protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects PPOX function (PMID: 12922165). For these reasons, this variant has been classified as Pathogenic. -
Variegate porphyria, childhood-onset Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at